Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like How To Prevent Failure in Rare Disease Trials? Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Opening Keynote: The Future of Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Solutions for Trial Design Challenges in Rare Disease Trials
Sign up to view this video Join Now Commercialization, • 9/19/25 What Matters to Payers: Conversations You Should Start During Phase 2 Previous Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Next Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories You Might Also Like How To Prevent Failure in Rare Disease Trials? Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Opening Keynote: The Future of Rare Disease Trials Accelerating Rare Disease Therapies: Strategies for Efficient Clinical Development Solutions for Trial Design Challenges in Rare Disease Trials
